Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LPCN compared with NXTC: revenue, margins and what each company keeps, and the suppliers and customers both name
LPCN
Lipocine Inc.
Change
Mkt cap
Revenue
Revenue
NXTC
NextCure, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LPCN
Lipocine Inc.
vs
NXTC
NextCure, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LPCN
0
None
Shared
0
No disclosed counterparties: LPCN.
Only NXTC
7
—
LigaChem Biosciences, Inc., formerly known as LegoChem Biosciences, Inc ("LigaChem")
unlisted
supplier
—
Simcere Zaiming Pharmaceutical Co., Ltd. (formerly known as Hainan Simcere Zaiming Pharmaceutical, Ltd. or hereinafter "Zaiming")
unlisted
supplier
—
WuXi XDC
unlisted
supplier
—
Yale University ("Yale")
unlisted
supplier
3 more · NXTC chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
LPCN
Lipocine Inc.
Change
1.59
▲
+3.92%
Mkt cap
$15.9M
Revenue
$2M
Q3 FY26
Revenue
$2M
FY25
NXTC
NextCure, Inc.
Change
5.12
▼
−12.48%
Regular session
Nov 6 '26
Mkt cap
$23.4M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 6 '26
LPCN
Lipocine Inc.
vs
NXTC
NextCure, Inc.
1.59
▲
+3.92%
Price
5.12
▼
−12.48%
$15.9M
Mkt cap
$23.4M
Q3 FY26
$2M
Revenue
—
FY25
$2M
Revenue
—
Change
Change
LPCN
1.59
▲
+3.92%
vs
NXTC
5.12
▼
−12.48%
Regular session
Nov 6 '26